Maple syrup urine disease: a possible biochemical basis for the clinical heterogeneity
- 1 September 1988
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 80 (1), 6-10
- https://doi.org/10.1007/bf00451447
Abstract
Summary Nine patients with maple syrup urine disease (MSUD), of whom eight were detected by mass-screening of neonates for inherited metabolic desease, were studied to determine possible relationships between clinical features and properties of the branched-chain α-keto acid dehydrogenase complex (BCKDH) in cultured lymphoblastoid cells. Based on their tolerance for leucine and on the clinical manifestations observed after 2 years of age, most could be classified into three types; classical (tolerate less than 600 mg of leucine per day, N=2), intermediate (N=3) and intermittent (N=3) types. In the other patient two of these three phenotypes were present. The BCKDH activities measured at a lower α-ketoisovaleric acid concentration (0.054 mM) were 0.026±0.015 in classical, 0.118±0.016 in intermediate and 0.625±0.139 in intermittent types and 7.052±0.779 (nmol/h per milligram of protein) in two controls, respectively; the differences being statistically significant (P, classical vs intermediate types; P, intermediate vs intermittent types; P, intermittent vs control). Kinetic and immunochemical analyses of the BCKDH revealed that, although there are a few exceptions, classical, intermediate and intermittent types correspond to the enzyme properties of sigmoidal kinetics with E1β subunit deficiency, near-sigmoidal kinetics with E1β subunit deficiency and hyperbolic kinetics with E2 subunit deficiency of the BCKDH, respectively.Keywords
This publication has 32 references indexed in Scilit:
- Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.JCI Insight, 1987
- Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.JCI Insight, 1985
- Intracellular levels and metabolism of leucine and α-ketoisocaproate in normal and maple syrup urine disease fibroblastsBiochemical Medicine, 1984
- Heterogeneity in maple syrup urine disease: Aspects of cofactor requirement and complementation in cultured fibroblastsClinical Genetics, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Complementation Analysis of Maple Syrup Urine Disease in Heterokaryons derived from Cultured Human FibroblastsNature, 1973
- Enzyme activity in classical and variant forms of maple syrup urine diseaseThe Journal of Pediatrics, 1972
- THIAMINE-RESPONSIVE MAPLE-SYRUP-URINE DISEASEThe Lancet, 1971
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- "Maple Syrup Urine Disease"BMJ, 1959